Biotechnology Law Technology 
Arnold Porter
NOVEMBER 4, 2021
News - Best Lawyers has named Arnold & Porter as a "Law Firm of the Year" in the "Litigation - Environmental" category. The firm also received 43 national rankings and 102 metropolitan rankings (Chicago, DC, Denver, Houston, Los Angeles, New York, and San Francisco) in the "Best Law Firms" report. Biotechnology Law.
Arnold Porter
JUNE 2, 2021
Arnold & Porter announced today that Dr. Amanda Antons has joined the firm’s Intellectual Property & Technology practice as counsel, resident in Chicago. She has significant research experience and knowledge in the biotechnology and the life sciences industries including work on T cell/HIV interactions.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Legal Planet
JULY 13, 2021
Importantly (and often misunderstood), he meant not that we are gods, but instead that technologies have given humanity powers that had previously been exclusive to the gods. I thus wrote the paper “ Earth System Interventions as Technologies of the Anthropocene ,” which was published (open access!)
National Sustainable Agriculture Coalition (NSAC)
OCTOBER 5, 2023
The Corporate Consolidation of Seed Breeding Over the past decades, we have seen a hyper consolidation of the seed market with over 50% of seed sales coming from companies that are owned by four large biotechnology corporations. Source: Philip H. To strictly analyze the cost of seed, consider that corn farmers who paid $26.65
Brag
NOVEMBER 28, 2022
Biological recycling, or biorecycling, is an emerging technology that uses microbes, such as bacteria or fungi, to break down plastic into its basic components for reuse. According to GAO, entities seeking to engage in biorecycling could face a “complicated legal landscape” that may pose a challenge for the emerging technology.
Arnold Porter
JUNE 2, 2021
The direct purchasers' suit, filed in 2012, alleged that GSK and Teva violated the antitrust laws through their settlement agreement to end a patent dispute over GSK's anti-epilepsy drug Lamictal and Teva's generic equivalent, lamotrigine.[[N:Complaint, and its subsidiary, AbbVie Biotechnology, Ltd. 3d 184 (3d Cir. Abbvie Inc.
ESA
SEPTEMBER 12, 2022
The Government Accountability Office issued five new priority recommendations to the White House Office of Science and Technology Policy. Revesz is a former dean and current professor at New York University’s School of Law and the founder of the Institute for Policy Integrity, an environmental think tank. Read the full report here.
Expert insights. Personalized for you.
75 
Let's personalize your content